dr. suzanne l. topalian on pd-l1 and emerging biomarkers for immunotherapy
Published 7 years ago • 135 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:08
dr. suzanne l. topalian on immunotherapy biomarkers in crc
-
1:43
dr. topalian on biomarkers for anti- pd-1 therapies in melanoma
-
1:02
dr. topalian on evolution of pd-1/pd-l1 agents in oncology
-
0:53
dr. suzanne topalian on the targeted pd-1 immunotherapy bms-936558
-
1:27
dr. suzanne topalian on the pd-1 targeted therapy bms-936558
-
37:07
immunotherapy for alzheimer's disease
-
1:37:00
peptides, bioregulators and longevity medicine with dr suzanne turner
-
5:50
understanding biomarkers
-
5:46
practical issues when treating with immunotherapy
-
1:04
sonja althammer on role of cd8 and pd-l1 biomarkers for immunotherapy in nsclc
-
36:45
symposium - suzanne topalian: harnessing the immune system to treat cancer
-
2:24
exploring the impact of anti-pd-1 and anti-pd-l1 agents in merkel cell carcinoma
-
1:09
dr. topalian on checkmate-358 for gynecologic malignancies
-
4:37
emerging biomarkers in lung cancer
-
9:55
suzanne topalian: anti-pd-1 (bms-936558, mdx-1106) in advanced solid tumors
-
11:40
toxicities associated with anti–pd-1 immunotherapy
-
6:21
the emergence of pd-l1 inhibitors
-
13:06
immunotherapy for melanoma, pt. 1: an overview
-
44:33
immunotherapy symposium - the birth of "ipi" and discovery of pd-1 antibodies
-
4:22
immunotherapy & melanoma: bloomberg~kimmel institute for cancer immunotherapy
-
1:11
dr. dung le on biomarker for pd-1 agents in crc
-
2:36
pd-l1 status in second-line lung adenocarcinoma